Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Filippos Porichis has not added Biography.
If you are Filippos Porichis and would like to personalize this page please email our Author Liaison for assistance.
Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Cancer letters Apr, 2006 | Pubmed ID: 15949894
In vitro cytopathic effects of mycotoxin T-2 on human peripheral blood T lymphocytes.
Toxicology letters Dec, 2005 | Pubmed ID: 16023801
HIV entry inhibitors: a new generation of antiretroviral drugs.
Acta pharmacologica Sinica Oct, 2005 | Pubmed ID: 16174430
A study of zearalenone cytotoxicity on human peripheral blood mononuclear cells.
Toxicology letters Sep, 2006 | Pubmed ID: 16797886
HIV-1 gp120/V3-derived epitopes promote activation-induced cell death to superantigen-stimulated CD4+/CD45RO+ T cells.
Immunology letters Jan, 2007 | Pubmed ID: 17141881
Activation-induced cell death signalling in CD4+ T cells by staphylococcal enterotoxin A.
Toxicology letters Jan, 2008 | Pubmed ID: 18054450
IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells.
Blood Jul, 2009 | Pubmed ID: 19365081
Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF.
Nature medicine Oct, 2010 | Pubmed ID: 20890291
Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10.
Journal of leukocyte biology Apr, 2011 | Pubmed ID: 21097698
HIV-specific CD4 T cells and immune control of viral replication.
Current opinion in HIV and AIDS May, 2011 | Pubmed ID: 21502921
Responsiveness of HIV-specific CD4 T cells to PD-1 blockade.
Blood Jul, 2011 | Pubmed ID: 21652684
HIV controllers: a multifactorial phenotype of spontaneous viral suppression.
Clinical immunology (Orlando, Fla.) Oct, 2011 | Pubmed ID: 21865089
The HIV-1 gp120/V3 modifies the response of uninfected CD4 T cells to antigen presentation: mapping of the specific transcriptional signature.
Journal of translational medicine , 2011 | Pubmed ID: 21943198
Role of PD-1 in HIV pathogenesis and as target for therapy.
Current HIV/AIDS reports Mar, 2012 | Pubmed ID: 22198819
CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes.
Journal of virology Jun, 2012 | Pubmed ID: 22496237
Prognostic value of tgfb1 protein in endometrioid adenocarcinoma.
European journal of clinical investigation Jan, 2013 | Pubmed ID: 23176363
High-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control.
Blood Jan, 2013 | Pubmed ID: 23233659
Cutting edge: Prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells.
Journal of immunology (Baltimore, Md. : 1950) Jul, 2013 | Pubmed ID: 23772031
Simultaneous TCR and CD244 Signals Induce Dynamic Downmodulation of CD244 on Human Antiviral T Cells.
Journal of immunology (Baltimore, Md. : 1950) Sep, 2013 | Pubmed ID: 23913963
The Ragon Institute of MGH, MIT and Harvard
Filippos Porichis*,1,
Meghan G. Hart*,1,
Jennifer Zupkosky1,
Lucie Barblu1,2,
Daniel E. Kaufmann1,2
1, The Ragon Institute of MGH, MIT and Harvard,
2, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.